22nd Century Group Inc. (XXII)
NASDAQ: XXIIHealth Care Medicinal Chemicals and Botanical Products USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
XXII stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.08M
- P/E (TTM)
- 0.00
- EPS (TTM)
- $4,528.07
- Dividend yield
- None
- 52-week range
- 0.295 – 20,323.20
- Day range
- 0.2993 – 0.3658
- Volume / Avg
- 1.68M / 1.21M
- Beta
- —
- Shares outstanding
- 3.21M
52-week range
XXII stock today
22nd Century Group (XXII) closed at $0.3365 on Nov 20, down 15.43% (-$0.0614), versus the S&P 500's 3.70% decline. At this level, XXII sits near the bottom of its 52-week range of $0.295 to $20,323.20: 100.0% below the high and 14.1% above the low. 22nd Century Group trades at 0.0x its trailing twelve-month earnings per share of $4,528.07.
Summary generated from market data by MetaCap's automated system. Methodology
About 22nd Century Group
Company profile22nd Century Group, Inc., a tobacco products company, manufactures, distributes, and sells proprietary new reduced nicotine tobacco products in the United States. The company offers reduced nicotine content tobacco and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands, as well as turnkey contract manufacturing of cigarettes and filtered cigars for other established tobacco brands.
- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
- CEO
- Mr. Lawrence D. Firestone
- Headquarters
- Mocksville, NC
- Employees
- 32
- Website
- xxiicentury.com
Financial highlights
Full financialsIn fiscal 2025, 22nd Century Group generated $17.6 million in revenue, down 27.9% from fiscal 2024, its first annual decline since 2024. 22nd Century Group reported a net loss of $5.1 million, compared with a loss of $15.2 million a year earlier. Gross margin was 42.1% (up from 41.4%) and operating margin -65.8%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $17.59M | $24.38M | $32.20M | $40.50M | $30.95M |
| Growth | -27.87% | -24.29% | -20.49% | +30.87% | +10.09% |
| Net income | $-5.05M | $-15.16M | $-140.78M | $-59.80M | $-32.61M |
| EPS (diluted) | $-52.87 | $-45,711.05 | $-15,925.99 | $-4.65 | $-0.21 |
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 16, 2026
- EPS actual vs est.
- $-227.49 vs —
XXII news
All XXII news- 22nd Century (XXII) Q3 2026 Earnings Call TranscriptNasdaq
- 22nd Century Group, Inc. Reports Third Quarter 2026 Revenue of $4.8 MillionNasdaq
- 22nd Century Group Reports Third Quarter 2026 Financial ResultsGlobeNewswire
- 22nd Century Group Consensus Price Target Increased by 5,700.00% to $159,732.00Nasdaq
- 22nd Century Group, Inc. Announces 1-for-58 Reverse Stock SplitNasdaq
- 22nd Century Group to Announce Third Quarter 2026 Results on November 16, 2026GlobeNewswire
- 22nd Century Signs Groundbreaking Agreement with GopuffGlobeNewswire
- 22nd Century Group Expands Pinnacle Brand Into 13 Newly Authorized States, Adding an Expected 360 Stores Nationwide for Pinnacle VLN® and Pinnacle PureGlobeNewswire
22nd Century Group peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| IMCCIM Cannabis Corp. | 0.4999 | +7.23% | $307.30K | vs XXII |
| MTEXMannatech Incorporated | 2.56 | +5.13% | $4.94M | vs XXII |
| NAIINatural Alternatives International Inc. | 0.876 | -2.67% | $5.48M | vs XXII |
| BONBon Natural Life Limited Class A | 1.04 | -0.50% | $8.53M | vs XXII |
| AKANAkanda Corp. | 4.23 | +23.32% | $11.16M | vs XXII |
| BTMDBiote Corp. Class A | 0.8147 | -3.56% | $26.28M | vs XXII |
| FTLFFitLife Brands Inc. | 6.20 | -7.46% | $58.22M | vs XXII |
| ISPRIspire Technology Inc. | 1.23 | -3.15% | $71.05M | vs XXII |
Indexes, lists and sector
22nd Century Group stock FAQ
What is 22nd Century Group's stock price today?
XXII last traded at $0.3365 as of Nov 20, 4:00 PM EST, down 15.43% on the day. Prices are delayed at least 15 minutes.
Does 22nd Century Group pay a dividend?
No. 22nd Century Group does not currently pay a regular cash dividend.
What is XXII's P/E ratio?
XXII trades at a trailing P/E ratio of 0.00.
Who is 22nd Century Group's CEO?
Mr. Lawrence D. Firestone is the chief executive officer of 22nd Century Group Inc., which has about 32 employees.
Has XXII ever split its stock?
Yes. The most recent XXII stock split was a 1-for-58 split on Nov 5, 2026.
What is the XXII 52-week high?
The 52-week high for XXII is $20,323.20 and the 52-week low is $0.295. The stock is currently 100.0% below its high.